Green Alpha Advisors’s SOPHiA GENETICS SOPH Stock Holding History
Bought
Maintained
Sold
Other funds holding SOPH
GIM
ACM
ACM
RA
BPC
AIC
SCM
SAM
Green Alpha Advisors's SOPH Position: Q2 2026 in Review
Green Alpha Advisors reduced its SOPHiA GENETICS (SOPH) stake by 0.44% in Q2 2026, selling an estimated $949 and leaving 42,765 shares worth $247K. The position accounts for 0.17% of the portfolio, ranked #93.
Green Alpha Advisors first reported a position in SOPH in Q3 2024 and has held it in 8 quarters since. 72 funds tracked by Wall St. Rank hold SOPH as of Q2 2026.
- Green Alpha Advisors held 42,765 shares of SOPHiA GENETICS worth $247K as of Q2 2026.
- Green Alpha Advisors sold 187 SOPHiA GENETICS shares in Q2 2026, an estimated $949.
- SOPHiA GENETICS made up 0.17% of Green Alpha Advisors's portfolio in Q2 2026, its #93 holding.
- Green Alpha Advisors first reported a position in SOPHiA GENETICS in Q3 2024 and has held it in 8 quarters since.
- 72 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q2 2026.
Based on Green Alpha Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.